ISSN 2639-9431
Vol. 8, Issue 4, 2025December 05, 2025 EDT
Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for Hyperargininemia
Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for Hyperargininemia
Jad Madani, B.S., Humza N. Zubair, B.S., Ghazi A. Saroya, B.S., Rachel E.N. Reyes, Ph.D, Rami Madani, B.S.,
Articles in Vol. 8, Issue 4, 2025
Vol. 8, Issue 4, 2025
- Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain DeliveryDarshan KAAnita R DesaiMallappa ShalavadiBasavaraj S. NainegaliLaxman S Vijapur
- GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic AnalysisFederico GrecoMarco CataldoAndrea PanunzioAlessandro TafuriBruno Beomonte ZobelCarlo Augusto Mallio
- A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of EndometriosisRusul F. AbediAhmed Jasim MohammedAbbas ChyadRedha Dawud Abd AlredhaGhanim A. AbbasKrarr Haider Haddawi
- Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for HyperargininemiaJad MadaniHumza N. ZubairGhazi A. SaroyaRachel E.N. ReyesRami Madani
- From BioMAG® to Feraheme®: Overview of the Intellectual Property HistoryErnest GromanDmitri Simberg
Madani, Jad, Humza N. Zubair, Ghazi A. Saroya, Rachel E.N. Reyes, and Rami Madani. 2025. “Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for Hyperargininemia.” Precision Nanomedicine 8 (4): 1634–44. https://doi.org/10.33218/001c.153885.